Clinical Trial Detail

NCT ID NCT03620435
Title Trimodal Therapy Plus Atezolizumab in Muscle-invasive Bladder Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors McGill University Health Center
Indications

bladder urothelial carcinoma

Therapies

Atezolizumab

Age Groups: senior adult

No variant requirements are available.